Cadence Pharmaceuticals, Inc. to Present at Three Investment Conferences During the Month of May 2013
5/9/2013 6:24:32 AM
More...
|
Cadence Pharmaceuticals, Inc. Reports First Quarter 2013 Financial Results
5/3/2013 6:29:47 AM
More...
|
Cadence Pharmaceuticals, Inc. to Host Conference Call and Webcast to Discuss First Quarter 2013 Financial Results on May 2, 2013
4/26/2013 7:35:30 AM
More...
|
Cadence Pharmaceuticals, Inc. Appoints Stephen L. Newman, M.D., to Its Board of Directors
3/15/2013 7:58:39 AM
More...
|
Cadence Pharmaceuticals, Inc. Announces the Availability of OFIRMEV® (Acetaminophen) InjectionTthrough the VA National Formulary
3/12/2013 10:21:23 AM
More...
|
Cadence Pharmaceuticals, Inc. Announces Strategic Plan to Secure Long-Term Manufacture and Supply of OFIRMEV® (Acetaminophen) Injection
3/7/2013 9:59:13 AM
More...
|
Cadence Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2012 Financial Results
3/7/2013 6:49:07 AM
More...
|
Cadence Pharmaceuticals, Inc. to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2012 Financial Results on March 7, 2013
3/1/2013 9:46:44 AM
More...
|
Cadence Pharmaceuticals, Inc.' CEO Ted Schroeder to Present at the Cowen and Company 33rd Annual Health Care Conference in Boston on March 5, 2013
2/27/2013 6:54:10 AM
More...
|
Cadence Pharmaceuticals, Inc.' CEO Ted Schroeder to Present at the Leerink Swann and Company Global Healthcare Conference in New York City on February 13, 2013
2/7/2013 7:57:13 AM
More...
|
|